Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20Nasopharyngeal Carcinoma 8Lung Neoplasms 7Colorectal Neoplasms 4Melanoma 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Osteosarcoma 2Nasopharyngeal Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Pleural Effusion, Malignant 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

endostar protein 1coenzyme Q10 1apatinib 1Yoga 1Ubiquinone 1Tamoxifen 1Referral and Consultation 1Palliative Care 1Oxaliplatin 1Melatonin 1Gardening 1Exercise 1Educational Status 1Diet Therapy 1Chemoradiotherapy 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Quality of Life × endostar protein × Clear all
NCT03588494 2018-07-17

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Affiliated Hospital of North Sichuan Medical College

Phase 2/3 Unknown
318 enrolled

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡